Latest / The Pulse with Mary Delaney
The GLP-1 Tipping Point: How Skyrocketing Costs Exposed PBM Influence and How Employers Can Take Back Control
GLP-1 medications have been a tipping point in exposing the role that PBM’s have over controlling prescription drug access and cost. Not all PBM’s are created equal and most drive what is easiest and most profitable for the PBM. It’s critical that employers play an active role in controlling their health plan strategy to support improved health outcomes and health plan investments. Tune into this episode of The Pulse as we uncover the role of the PBM in prescription drug access and costs and what employers need to do to redefine expectations and outcomes from PBMs.Panelists will discuss:How a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.